BDNF and Huntington disease: Interventions targeting this cellular axis—such as enhancing BDNF signaling, restoring NMDAR balance, or stabilizing AMPARs—offer potential strategies to disrupt this cycle and mitigate HD-related synaptic and behavioral impairments.